Deutsche Bank’s AMAG Pharmaceuticals AMAG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q1
Sell
-539
Closed -$8K 5544
2018
Q4
$8K Hold
539
﹤0.01% 4917
2018
Q3
$11K Buy
+539
New +$12.3K ﹤0.01% 5067

Deutsche Bank's AMAG Position: Q4 2020 in Review

Deutsche Bank sold out of AMAG Pharmaceuticals (AMAG) in Q4 2020, closing a stake of 15,823 shares — an estimated $149K sold.

Deutsche Bank first reported a position in AMAG in Q2 2013 and held it in 30 quarters. The position peaked at $13.7M in Q4 2016. 1 fund tracked by Wall St. Rank holds AMAG as of Q4 2020.

  • Deutsche Bank reported no remaining AMAG Pharmaceuticals position as of Q4 2020 after selling out during the quarter.
  • Deutsche Bank sold 15,823 AMAG Pharmaceuticals shares in Q4 2020, an estimated $149K.
  • Deutsche Bank first reported a position in AMAG Pharmaceuticals in Q2 2013 and held it in 30 quarters.
  • Deutsche Bank's AMAG Pharmaceuticals position peaked at $13.7M in Q4 2016.
  • 1 fund tracked by Wall St. Rank held AMAG Pharmaceuticals as of Q4 2020.

Based on Deutsche Bank's 13F filing for Q4 2020, filed 16 Feb 2021.